← All trials
NCT01909661
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2013
- Primary completion
- Aug 31, 2014
- Completion date
- Aug 31, 2014
- First posted
- Jul 26, 2013
- Last posted
- Apr 17, 2015
- Enrollment
- 114
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- LactalisLead sponsor
- Biosearch S.A.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.